https://www.selleckchem.com/products/tpx-0005.html
Postprandial symptoms presumably related to intestinal gas production are common in patients with irritable bowel syndrome (IBS). The aim of the study was to assess if oral α-galactosidase is superior to placebo in reducing gastrointestinal (GI) symptoms and intestinal gas production after ingestion of carbohydrate-rich meals in adult patients with IBS. We studied the effect of 1200GaIU/meal α-galactosidase (Nogasin ) or placebo capsules on GI symptoms in patients with IBS after three standardized, meals high in oligosaccharides, in a
Like
Comment
Share
